Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CNS penetration of potential anti-COVID-19 drugs.
Richardson PJ, Ottaviani S, Prelle A, Stebbing J, Casalini G, Corbellino M. Richardson PJ, et al. Among authors: corbellino m. J Neurol. 2020 Jul;267(7):1880-1882. doi: 10.1007/s00415-020-09866-5. Epub 2020 May 2. J Neurol. 2020. PMID: 32361836 Free PMC article. Review. No abstract available.
Baricitinib for COVID-19: a suitable treatment? - Authors' reply.
Richardson PJ, Corbellino M, Stebbing J. Richardson PJ, et al. Among authors: corbellino m. Lancet Infect Dis. 2020 Sep;20(9):1013-1014. doi: 10.1016/S1473-3099(20)30270-X. Epub 2020 Apr 3. Lancet Infect Dis. 2020. PMID: 32251639 Free PMC article. No abstract available.
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
Stebbing J, Krishnan V, de Bono S, Ottaviani S, Casalini G, Richardson PJ, Monteil V, Lauschke VM, Mirazimi A, Youhanna S, Tan YJ, Baldanti F, Sarasini A, Terres JAR, Nickoloff BJ, Higgs RE, Rocha G, Byers NL, Schlichting DE, Nirula A, Cardoso A, Corbellino M; Sacco Baricitinib Study Group. Stebbing J, et al. Among authors: corbellino m. EMBO Mol Med. 2020 Aug 7;12(8):e12697. doi: 10.15252/emmm.202012697. Epub 2020 Jun 24. EMBO Mol Med. 2020. PMID: 32473600 Free PMC article.
Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19.
Sims JT, Krishnan V, Chang CY, Engle SM, Casalini G, Rodgers GH, Bivi N, Nickoloff BJ, Konrad RJ, de Bono S, Higgs RE, Benschop RJ, Ottaviani S, Cardoso A, Nirula A, Corbellino M, Stebbing J. Sims JT, et al. Among authors: corbellino m. J Allergy Clin Immunol. 2021 Jan;147(1):107-111. doi: 10.1016/j.jaci.2020.08.031. Epub 2020 Sep 10. J Allergy Clin Immunol. 2021. PMID: 32920092 Free PMC article.
Limbic encephalitis in a COVID-19 patient?
Chiveri L, Verrengia E, Muscia F, Nuzzaco G, Raimondi E, Vecchio E, Bompane D, Mazzone A, Fociani P, Corbellino M, Prelle A. Chiveri L, et al. Among authors: corbellino m. J Neurovirol. 2021 Jun;27(3):498-500. doi: 10.1007/s13365-021-00971-3. Epub 2021 Mar 31. J Neurovirol. 2021. PMID: 33825173 Free PMC article.
Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients.
Sims JT, Chang CY, Poorbaugh J, Daniels M, Beasley SL, Zhang L, Rodgers GH, Lena F, Lacerenza LG, Sposato B, Dupont A, Susen S, Casalini G, Corbellino M, Stebbing J, Krishnan V. Sims JT, et al. Among authors: corbellino m. J Transl Med. 2022 Sep 8;20(1):411. doi: 10.1186/s12967-022-03583-5. J Transl Med. 2022. PMID: 36076201 Free PMC article. No abstract available.
Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease.
Colaneri M, Scaglione G, Fassio F, Galli L, Lai A, Bergna A, Gabrieli A, Tarkowski M, Ventura CD, Colombo V, Cordier L, Bernasconi D, Corbellino M, Dedivitiis G, Borghetti S, Visigalli D, Sollima S, Casalini G, Rizzardini G, Gori A, Antinori S, Riva A, Schiavini M. Colaneri M, et al. Among authors: corbellino m. Virol J. 2024 Mar 20;21(1):68. doi: 10.1186/s12985-024-02333-x. Virol J. 2024. PMID: 38509536 Free PMC article.
Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?
Baldelli S, Corbellino M, Clementi E, Cattaneo D, Gervasoni C. Baldelli S, et al. Among authors: corbellino m. J Antimicrob Chemother. 2020 Sep 1;75(9):2704-2706. doi: 10.1093/jac/dkaa190. J Antimicrob Chemother. 2020. PMID: 32407513 Free PMC article. No abstract available.
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
Antinori S, Cossu MV, Ridolfo AL, Rech R, Bonazzetti C, Pagani G, Gubertini G, Coen M, Magni C, Castelli A, Borghi B, Colombo R, Giorgi R, Angeli E, Mileto D, Milazzo L, Vimercati S, Pellicciotta M, Corbellino M, Torre A, Rusconi S, Oreni L, Gismondo MR, Giacomelli A, Meroni L, Rizzardini G, Galli M. Antinori S, et al. Among authors: corbellino m. Pharmacol Res. 2020 Aug;158:104899. doi: 10.1016/j.phrs.2020.104899. Epub 2020 May 11. Pharmacol Res. 2020. PMID: 32407959 Free PMC article. Clinical Trial.
144 results